The innate immune system and inflammatory bowel disease

Area of Science:

• Immunology
• Gastroenterology

Background:

• The innate immune system is central to inflammatory bowel disease (IBD) pathogenesis.
• NOD2 and IL-23 receptor polymorphisms are linked to IBD susceptibility.
• IBD pathogenesis involves defects in controlling commensal and pathogenic bacteria.

Purpose of the Study:

• To explore the role of innate immunity in IBD.
• To identify potential therapeutic targets within innate immune pathways.

Main Methods:

• Review of genetic studies (GWAS) identifying IBD susceptibility genes.
• Analysis of cellular defects in IBD, including epithelial and phagocytic cell dysfunction.
• Consideration of recent findings on innate lymphoid cells (ILCs).

Main Results:

• Genetic studies highlight NOD2 and IL-23 receptor involvement in IBD.
• IBD is associated with impaired bacterial clearance due to epithelial or phagocytic cell defects.
• Innate lymphoid cells expressing IL-23 receptor add complexity to immune responses in IBD.

Conclusions:

• Defects in innate immune responses to bacteria are central to IBD.
• Further understanding of innate cytokines, beyond TNF inhibitors, is needed for effective IBD treatment.
• Targeting innate immune pathways holds promise for novel IBD therapies.